Literature DB >> 2165062

Cholesterol sulfate inhibits the fusion of Sendai virus to biological and model membranes.

J J Cheetham1, R M Epand, M Andrews, T D Flanagan.   

Abstract

Cholesterol sulfate is a component of several biological membranes. In erythrocytes, cholesterol sulfate inhibits hypotonic hemolysis, while in sperm, it can decrease fertilization efficiency. We have found cholesterol sulfate to be a potent inhibitor of Sendai virus fusion to both human erythrocyte and liposomal membranes. Cholesterol sulfate also raises the bilayer to hexagonal phase transition temperature of dielaidoyl phosphatidylethanolamine as demonstrated by differential scanning calorimetry and 31P nuclear magnetic resonance spectrometry. Although hexagonal phase structures are not readily found in biological membranes, there is a correlation between the effects of membrane additives on bilayer/non-bilayer equilibria and membrane stabilization. It is proposed that the ability of cholesterol sulfate to alter the physical properties of membranes contributes to its stabilization of biological membranes and the inhibition of membrane fusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165062

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.

Authors:  Angela C Brown; Kathleen Boesze-Battaglia; Yurong Du; Frank P Stefano; Irene R Kieba; Raquel F Epand; Lazaros Kakalis; Philip L Yeagle; Richard M Epand; Edward T Lally
Journal:  Cell Microbiol       Date:  2012-03-28       Impact factor: 3.715

2.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Reversible surface aggregation in pore formation by pardaxin.

Authors:  D Rapaport; R Peled; S Nir; Y Shai
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

4.  Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes.

Authors:  Kirsten Bacia; Petra Schwille; Teymuras Kurzchalia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

5.  Molecular dynamics simulation of dipalmitoylphosphatidylcholine membrane with cholesterol sulfate.

Authors:  A M Smondyrev; M L Berkowitz
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

6.  Comparative effects of cholesterol and cholesterol sulfate on hydration and ordering of dimyristoylphosphatidylcholine membranes.

Authors:  C Faure; J F Tranchant; E J Dufourc
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

7.  Interaction of 3β-amino-5-cholestene with phospholipids in binary and ternary bilayer membranes.

Authors:  Max Lönnfors; Oskar Engberg; Blake R Peterson; J Peter Slotte
Journal:  Langmuir       Date:  2011-12-14       Impact factor: 3.882

8.  A biosynthetic pathway for the selective sulfonation of steroidal metabolites by human gut bacteria.

Authors:  Lina Yao; Gabriel D D'Agostino; Jinseok Park; Saiyu Hang; Arijit A Adhikari; Yancong Zhang; Wei Li; Julian Avila-Pacheco; Sena Bae; Clary B Clish; Eric A Franzosa; Curtis Huttenhower; Jun R Huh; A Sloan Devlin
Journal:  Nat Microbiol       Date:  2022-08-18       Impact factor: 30.964

9.  Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.

Authors:  Michelle de la Vega; Mariana Marin; Naoyuki Kondo; Kosuke Miyauchi; Yuri Kim; Raquel F Epand; Richard M Epand; Gregory B Melikyan
Journal:  Retrovirology       Date:  2011-12-06       Impact factor: 4.602

10.  Influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity.

Authors:  Katarzyna E Zawada; Dominik Wrona; Robert J Rawle; Peter M Kasson
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.